Skip to content

Prospective Controlled Trial On Clear Feeds Versus Low Residue Diet After Surgery In Elective Colorectal Surgery Patients

PROSPECTIVE RANDOMIZED CONTROLLED TRIAL ON CLEAR FEEDS VERSUS LOW RESIDUE DIET AFTER SURGERY IN ELECTIVE COLORECTAL SURGERY PATIENTS.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01890499
Enrollment
104
Registered
2013-07-01
Start date
2012-11-30
Completion date
2013-09-30
Last updated
2015-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nausea/Vomiting

Keywords

tolerability, diet after operation

Brief summary

Prospective randomized controlled trial investigating commencement of low residue diet versus clear feeds on postoperative day one following elective colorectal surgery, with regards to patient tolerability, incidence of nausea and/or vomiting, and postoperative length of hospitalization stay.

Detailed description

Based on current literature, the incidence of postoperative nausea and vomiting varies widely and can reach up to 40% in abdominal surgery patients. Thus, patient tolerability to postoperative enteral feeds is taken as 60%. This is a superiority trial: group one is the clear feeds group and patient tolerability in this group is taken to be 60%. Group two is the low residue diet group. The primary hypothesis is that the incidence of postoperative ileus is not affected by the consistency of enteral diet given, and patients who are placed on low residue diet from postoperative day one do not have an increased risk of postoperative nausea and vomiting as compared to patients who are placed on clear feeds. The primary endpoint measured is Patient tolerability, as evidenced by development of vomiting on postoperative day two. Key Inclusion criteria are: 1. Able to freely give written informed consent to participate in the study and have signed the Informed Consent Form; 2. Males or females, \>18 years of age inclusive at the time of study screening; 3. American Society of Anesthesiologists (ASA) Class I-III; 4. Colorectal surgery (open and/or laparoscopic); 5. Elective Surgery. Key Exclusion criteria are: 1. Mentally incompetent or unable or unwilling to provide informed consent or comply with study procedures. 2. Children \<18 years of age. 3. Pre-operative clinical diagnosis of intestinal obstruction. 4. Pre-existing known upper gastrointestinal disorders. 5. Pre-existing oropharyngeal disorders such as stomatitis, altered taste sensations. 6. Open upper abdominal surgical incisions. 7. Colorectal surgery with concomitant resectional surgery of the stomach or proximal jejunum (small bowel). 8. Pregnant patients. 9. Bedbound or moribund patients. 10. Pre-existing history of clinical depression. 11. Epidural analgesia.

Interventions

DIETARY_SUPPLEMENTLow Residue diet arm.

Interventional arm is to provide low residue diet on postoperative day one.

Sponsors

Cedars-Sinai Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Able to freely give written informed consent to participate in the study and have signed the Informed Consent Form; 2. Males or females, \>18 years of age inclusive at the time of study screening; 3. American Society of Anesthesiologists (ASA) Class I-III; 4. Colorectal surgery (open and/or laparoscopic); 5. Elective Surgery.

Exclusion criteria

1. Mentally incompetent or unable or unwilling to provide informed consent or comply with study procedures. 2. Children \<18 years of age. 3. Pre-operative clinical diagnosis of intestinal obstruction. 4. Pre-existing known upper gastrointestinal disorders. 5. Pre-existing oropharyngeal disorders such as stomatitis, altered taste sensations. 6. Open upper abdominal surgical incisions. 7. Colorectal surgery with concomitant resectional surgery of the stomach or proximal jejunum (small bowel). 8. Pregnant patients. 9. Bedbound or moribund patients. 10. Pre-existing history of clinical depression. 11. Epidural analgesia.

Design outcomes

Primary

MeasureTime frame
Development of nausea and vomiting on postoperative day twopostoperative day two

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026